FDA Announces Final Guidance for Developing Drugs and Biologics for Renal Cell Carcinoma Adjuvant Treatment

Summary

The FDA has released a final guidance document to help pharmaceutical companies develop effective treatments for renal cell carcinoma, a type of kidney cancer, and provides recommendations for sponsors on the development process.